Ізраїль - англійська - Ministry of Health

gilead sciences israel ltd - sofosbuvir - film coated tablets - sofosbuvir 400 mg - sofosbuvir - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults.for hepatitis c virus (hcv) genotype specific activity, see physician leaflet .

Ізраїль - англійська - Ministry of Health

gilead sciences israel ltd - sofosbuvir - film coated tablets - sofosbuvir 400 mg - sofosbuvir - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults.for hepatitis c virus (hcv) genotype specific activity, see physician leaflet .

Ізраїль - англійська - Ministry of Health

gilead sciences israel ltd - efavirenz; emtricitabine; tenofovir disoproxil as - film coated tablets - tenofovir disoproxil as 245 mg; emtricitabine 200 mg; efavirenz 600 mg - tenofovir disoproxil - atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.

Європейський Союз - англійська - EMA (European Medicines Agency)

gilead sciences ireland uc - tenofovir alafenamide fumarate - hepatitis b - antivirals for systemic use, - vemlidy is indicated for the treatment of chronic hepatitis b in adults and adolescents (aged 12 years and older with body weight at least 35 kg).,

Європейський Союз - англійська - EMA (European Medicines Agency)

gilead sciences ireland uc - elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide - hiv infections - antivirals for systemic use, - genvoya is indicated for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus 1 (hiv 1) without any known mutations associated with resistance to the integrase inhibitor class, emtricitabine or tenofovir.,

Європейський Союз - англійська - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirals for systemic use - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

gilead sciences ireland uc - amphotericin b - concentrate for solution for infusion - 50 milligram(s) - antibiotics; amphotericin b

Ізраїль - англійська - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - solution for injection - lenacapavir as sodium 309 mg/ml - lenacapavir - sunlenca solution for injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Ізраїль - англійська - Ministry of Health

gilead sciences israel ltd - tenofovir disoproxil as fumarate - film coated tablets - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - viread is indicated for the treatment of :1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv. 2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease

Ізраїль - англійська - Ministry of Health

gilead sciences israel ltd - tenofovir disoproxil as fumarate - film coated tablets - tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - viread is indicated for the treatment of :1. hiv 1 infected adults and pediatric patients 12 years of age and older in combination with other antiretroviral medicinal products for the treatment of hiv. 2. chronic hepatitis b in adults with: • compensated liver disease, with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. • decompensated liver disease